PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
GMED vs. INMD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GMED and INMD is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

GMED vs. INMD

Last updated May 30, 2025

Compare and contrast key facts about Globus Medical, Inc. (GMED) and InMode Ltd. (INMD).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GMED or INMD.

Performance

GMED vs. INMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Globus Medical, Inc. (GMED) and InMode Ltd. (INMD). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

GMED:

-0.27

INMD:

-0.50

Sortino Ratio

GMED:

-0.13

INMD:

-0.39

Omega Ratio

GMED:

0.98

INMD:

0.95

Calmar Ratio

GMED:

-0.26

INMD:

-0.25

Martin Ratio

GMED:

-0.78

INMD:

-1.46

Ulcer Index

GMED:

13.50%

INMD:

14.45%

Daily Std Dev

GMED:

36.90%

INMD:

44.74%

Max Drawdown

GMED:

-47.91%

INMD:

-85.59%

Current Drawdown

GMED:

-36.89%

INMD:

-85.09%

Fundamentals

Market Cap

GMED:

$8.07B

INMD:

$919.06M

EPS

GMED:

$1.33

INMD:

$2.23

PE Ratio

GMED:

44.52

INMD:

6.45

PEG Ratio

GMED:

1.72

INMD:

2.90

PS Ratio

GMED:

3.21

INMD:

2.34

PB Ratio

GMED:

1.97

INMD:

1.43

Total Revenue (TTM)

GMED:

$2.51B

INMD:

$392.41M

Gross Profit (TTM)

GMED:

$1.43B

INMD:

$314.06M

EBITDA (TTM)

GMED:

$486.48M

INMD:

$110.79M

Returns By Period

In the year-to-date period, GMED achieves a -28.80% return, which is significantly lower than INMD's -12.63% return.

GMED

YTD

-28.80%

1M

-18.58%

6M

-30.95%

1Y

-9.77%

3Y*

-4.12%

5Y*

1.51%

10Y*

8.72%

INMD

YTD

-12.63%

1M

1.18%

6M

-25.14%

1Y

-22.23%

3Y*

-18.18%

5Y*

-0.09%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Globus Medical, Inc.

InMode Ltd.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GMED vs. INMD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
GMED
The Risk-Adjusted Performance Rank of GMED is 3333
Overall Rank
The Sharpe Ratio Rank of GMED is 3636
Sharpe Ratio Rank
The Sortino Ratio Rank of GMED is 3232
Sortino Ratio Rank
The Omega Ratio Rank of GMED is 3030
Omega Ratio Rank
The Calmar Ratio Rank of GMED is 3434
Calmar Ratio Rank
The Martin Ratio Rank of GMED is 3232
Martin Ratio Rank
INMD
The Risk-Adjusted Performance Rank of INMD is 2323
Overall Rank
The Sharpe Ratio Rank of INMD is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of INMD is 2424
Sortino Ratio Rank
The Omega Ratio Rank of INMD is 2525
Omega Ratio Rank
The Calmar Ratio Rank of INMD is 3535
Calmar Ratio Rank
The Martin Ratio Rank of INMD is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GMED vs. INMD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and InMode Ltd. (INMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GMED Sharpe Ratio is -0.27, which is higher than the INMD Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of GMED and INMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GMED vs. INMD - Dividend Comparison

Neither GMED nor INMD has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

GMED vs. INMD - Drawdown Comparison

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum INMD drawdown of -85.59%. Use the drawdown chart below to compare losses from any high point for GMED and INMD.

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GMED vs. INMD - Volatility Comparison

Globus Medical, Inc. (GMED) has a higher volatility of 28.19% compared to InMode Ltd. (INMD) at 9.07%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than INMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

GMED vs. INMD - Financials Comparison

This section allows you to compare key financial metrics between Globus Medical, Inc. and InMode Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.00100.00M200.00M300.00M400.00M500.00M600.00M700.00M20212022202320242025
598.12M
77.87M
(GMED) Total Revenue
(INMD) Total Revenue
Values in USD except per share items

GMED vs. INMD - Profitability Comparison

The chart below illustrates the profitability comparison between Globus Medical, Inc. and InMode Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.
Gross Margin
Operating Margin
Net Margin
Quarterly
Annual
50.0%60.0%70.0%80.0%90.0%20212022202320242025
67.3%
78.2%
(GMED) Gross Margin
(INMD) Gross Margin
GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported a gross profit of 402.72M and revenue of 598.12M. Therefore, the gross margin over that period was 67.3%.

INMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, InMode Ltd. reported a gross profit of 60.91M and revenue of 77.87M. Therefore, the gross margin over that period was 78.2%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported an operating income of 97.00M and revenue of 598.12M, resulting in an operating margin of 16.2%.

INMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, InMode Ltd. reported an operating income of 15.62M and revenue of 77.87M, resulting in an operating margin of 20.1%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported a net income of 75.46M and revenue of 598.12M, resulting in a net margin of 12.6%.

INMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, InMode Ltd. reported a net income of 18.20M and revenue of 77.87M, resulting in a net margin of 23.4%.